Literature DB >> 22407275

Co-segregation of DM2 with a recessive CLCN1 mutation in juvenile onset of myotonic dystrophy type 2.

Rosanna Cardani1, Marzia Giagnacovo, Annalisa Botta, Fabrizio Rinaldi, Alessandra Morgante, Bjarne Udd, Olayinka Raheem, Sini Penttilä, Tiina Suominen, Laura V Renna, Valeria Sansone, Enrico Bugiardini, Giuseppe Novelli, Giovanni Meola.   

Abstract

Myotonic dystrophy type 2 (DM2) is a common adult onset muscular dystrophy caused by a dominantly transmitted (CCTG)( n ) expansion in intron 1 of the CNBP gene. In DM2 there is no obvious evidence for an intergenerational increase of expansion size, and no congenital cases have been confirmed. We describe the clinical and histopathological features, and provide the genetic and molecular explanation for juvenile onset of myotonia in a 14-year-old female with DM2 and her affected mother presenting with a more severe phenotype despite a later onset of symptoms. Histological and immunohistochemical findings correlated with disease severity or age at onset in both patients. Southern blot on both muscle and blood samples revealed only a small increase in the CCTG repeat number through maternal transmission. Fluorescence in situ hybridization, in combination with MBNL1 immunofluorescence on muscle sections, showed the presence of mutant mRNA and MBNL1 in nuclear foci; the fluorescence intensity and its area appeared to be similar in the two patients. Splicing analysis of the INSR, CLCN1 and MBNL1 genes in muscle tissue demonstrates that the level of aberrant splicing isoforms was lower in the daughter than in the mother. However, in the CLCN1 gene, a heterozygous mutation c.501C>G p.F167L was present in the daughter's DNA and found to be maternally inherited. Biomolecular findings did not explain the unusual young onset in the daughter. The co-segregation of DM2 with a recessive CLCN1 mutation provided the explanation for the unusual clinical findings.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22407275     DOI: 10.1007/s00415-012-6462-1

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  30 in total

1.  Biomolecular identification of (CCTG)n mutation in myotonic dystrophy type 2 (DM2) by FISH on muscle biopsy.

Authors:  R Cardani; E Mancinelli; V Sansone; G Rotondo; G Meola
Journal:  Eur J Histochem       Date:  2004 Oct-Dec       Impact factor: 3.188

2.  Myotonia congenita and myotonic dystrophy in the same family: coexistence of a CLCN1 mutation and expansion in the CNBP (ZNF9) gene.

Authors:  C Sun; M Van Ghelue; L Tranebjærg; F Thyssen; Ø Nilssen; T Torbergsen
Journal:  Clin Genet       Date:  2011-01-19       Impact factor: 4.438

3.  Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy.

Authors:  R S Savkur; A V Philips; T A Cooper
Journal:  Nat Genet       Date:  2001-09       Impact factor: 38.330

Review 4.  Myotonic dystrophy type 2 and related myotonic disorders.

Authors:  Giovanni Meola; Richard T Moxley
Journal:  J Neurol       Date:  2004-10       Impact factor: 4.849

5.  Functional consequences of chloride channel gene (CLCN1) mutations causing myotonia congenita.

Authors:  J Zhang; S Bendahhou; M C Sanguinetti; L J Ptácek
Journal:  Neurology       Date:  2000-02-22       Impact factor: 9.910

6.  Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophy.

Authors:  Rahul N Kanadia; Jihae Shin; Yuan Yuan; Stuart G Beattie; Thurman M Wheeler; Charles A Thornton; Maurice S Swanson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-24       Impact factor: 11.205

7.  Genetic mapping of a second myotonic dystrophy locus.

Authors:  L P Ranum; P F Rasmussen; K A Benzow; M D Koob; J W Day
Journal:  Nat Genet       Date:  1998-06       Impact factor: 38.330

8.  Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member.

Authors:  J D Brook; M E McCurrach; H G Harley; A J Buckler; D Church; H Aburatani; K Hunter; V P Stanton; J P Thirion; T Hudson
Journal:  Cell       Date:  1992-02-21       Impact factor: 41.582

Review 9.  Myotonia caused by mutations in the muscle chloride channel gene CLCN1.

Authors:  Michael Pusch
Journal:  Hum Mutat       Date:  2002-04       Impact factor: 4.878

10.  Preferential central nucleation of type 2 myofibers is an invariable feature of myotonic dystrophy type 2.

Authors:  Valerio Pisani; Maria Beatrice Panico; Chiara Terracciano; Emanuela Bonifazi; Giovanni Meola; Giuseppe Novelli; Giorgio Bernardi; Corrado Angelini; Roberto Massa
Journal:  Muscle Nerve       Date:  2008-11       Impact factor: 3.217

View more
  17 in total

Review 1.  Myotonic dystrophy type 2 and modifier genes: an update on clinical and pathomolecular aspects.

Authors:  Giovanni Meola; Rosanna Cardani
Journal:  Neurol Sci       Date:  2017-01-11       Impact factor: 3.307

Review 2.  Biomolecular diagnosis of myotonic dystrophy type 2: a challenging approach.

Authors:  Giovanni Meola; Fiammetta Biasini; Rea Valaperta; Elena Costa; Rosanna Cardani
Journal:  J Neurol       Date:  2017-05-26       Impact factor: 4.849

3.  Translating genetic and functional data into clinical practice: a series of 223 families with myotonia.

Authors:  Karen Suetterlin; Emma Matthews; Richa Sud; Samuel McCall; Doreen Fialho; James Burge; Dipa Jayaseelan; Andrea Haworth; Mary G Sweeney; Dimitri M Kullmann; Stephanie Schorge; Michael G Hanna; Roope Männikkö
Journal:  Brain       Date:  2022-04-18       Impact factor: 15.255

4.  Coexistence of CLCN1 and SCN4A mutations in one family suffering from myotonia.

Authors:  Lorenzo Maggi; Sabrina Ravaglia; Alessandro Farinato; Raffaella Brugnoni; Concetta Altamura; Paola Imbrici; Diana Conte Camerino; Alessandro Padovani; Renato Mantegazza; Pia Bernasconi; Jean-François Desaphy; Massimiliano Filosto
Journal:  Neurogenetics       Date:  2017-10-09       Impact factor: 2.660

5.  Paroxysmal kinesigenic dyskinesia and myotonia congenita in the same family: coexistence of a PRRT2 mutation and two CLCN1 mutations.

Authors:  Hong-Fu Li; Wan-Jin Chen; Wang Ni; Zhi-Ying Wu
Journal:  Neurosci Bull       Date:  2014-09-05       Impact factor: 5.203

6.  Targeted Therapies for Skeletal Muscle Ion Channelopathies: Systematic Review and Steps Towards Precision Medicine.

Authors:  Jean-François Desaphy; Concetta Altamura; Savine Vicart; Bertrand Fontaine
Journal:  J Neuromuscul Dis       Date:  2021

Review 7.  ClC-1 chloride channels: state-of-the-art research and future challenges.

Authors:  Paola Imbrici; Concetta Altamura; Mauro Pessia; Renato Mantegazza; Jean-François Desaphy; Diana Conte Camerino
Journal:  Front Cell Neurosci       Date:  2015-04-27       Impact factor: 5.505

8.  Functional characterization of ClC-1 mutations from patients affected by recessive myotonia congenita presenting with different clinical phenotypes.

Authors:  Jean-François Desaphy; Gianluca Gramegna; Concetta Altamura; Maria Maddalena Dinardo; Paola Imbrici; Alfred L George; Anna Modoni; Mauro Lomonaco; Diana Conte Camerino
Journal:  Exp Neurol       Date:  2013-08-08       Impact factor: 5.330

9.  Overexpression of CUGBP1 in skeletal muscle from adult classic myotonic dystrophy type 1 but not from myotonic dystrophy type 2.

Authors:  Rosanna Cardani; Enrico Bugiardini; Laura V Renna; Giulia Rossi; Graziano Colombo; Rea Valaperta; Giuseppe Novelli; Annalisa Botta; Giovanni Meola
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

Review 10.  Therapeutic Approaches to Genetic Ion Channelopathies and Perspectives in Drug Discovery.

Authors:  Paola Imbrici; Antonella Liantonio; Giulia M Camerino; Michela De Bellis; Claudia Camerino; Antonietta Mele; Arcangela Giustino; Sabata Pierno; Annamaria De Luca; Domenico Tricarico; Jean-Francois Desaphy; Diana Conte
Journal:  Front Pharmacol       Date:  2016-05-10       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.